Vincristine Sulfate

硫酸长春新碱

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameVincristine Sulfate
Drug Alias NameLeurocristine sulfate长春新碱硫酸盐硫酸醛基长春碱Vincristinum硫酸长春醛碱 +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin polymerisation inhibitors
TargetsTubulin
Therapy Area/IndicationsSmall Cell Lung CarcinomaCarcinoma, BronchogenicBrain Neoplasms +[20] 
Global Approved IndicationsSmall Cell Lung CarcinomaCarcinoma, BronchogenicBreast Neoplasms +[17] 
Approved Indications in ChinaSmall Cell Lung CarcinomaCarcinoma, BronchogenicBreast Neoplasms +[14] 
Original Approved Country/TerritoryUnited States
Original Approved Date1963/07/10
Country/TerritoryCanadaUnited StatesGermany +[9] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And CompanyPharmacia Sverige AktiebolagAcrotech Biopharma Llc +[7] 
Inactive CompaniesAcrotech Biopharma IncInex PharmaceuticalsWake Forest University Health Sciences +[9] 
Active IndicationsSmall Cell Lung CarcinomaCarcinoma, BronchogenicBreast Neoplasms +[16] 
Inactive IndicationsBrain NeoplasmsOsteosarcomaLeukemia, Myeloid, Acute +[4] 

Other Information

ATC CodeL01CA02
Related LinksWikipediaDrugBankKEGG